Comparison of serum and bronchoalveolar lavage fluid sialic acid levels between malignant and benign lung diseases

Description

Background It is known that tissue and serum sialic acid levels may be altered by malignant transformation. In this study, sialic acid levels were determined in bronchoalveolar lavage fluid (BAL) and serum in two groups of patients with lung cancer and non-malignant diseases of the lung. Methods Colorimetric methods were used for determination sialic acid in serum and in BAL samples. Flexible bronchoscopy was used to obtain the latter. Results Sialic acid levels in bronchoalveolar lavage fluid and serum did not show any statistically significant difference between subjects with malignant and the non-malignant lung diseases (p > 0.05). Sialic acid levels were also unrelated to the stage and localization of the tumor (p > 0.05). Conclusions Sialic acid levels do not appear to be a good marker for discriminating malignant from non-malignant diseases of the lung.

Resources

Name Format Description Link
21 Visit the original government dataset for complete information, documentation, and data access. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64545/

Tags

  • bronchoalveolar-lavage
  • lung-cancer-diagnosis
  • nih
  • biomarker-study
  • sialic-acid

Topics

Categories